Patents-Review.com
ClassID:

21226 ⎘

A61K2039/62 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier

Sub-classes:
Recent Application in this class:
#1
20260132171
2026-05-14

PRE-FUSION-STABILIZED CMV GB PROTEIN NANOSTRUCTURES

 #2
20260115271
2026-04-30

MULTIVALENT PNEUMOCOCCAL VACCINES

 #3
20260053906
2026-02-26

DNA ORIGAMI VACCINES

 #4
20250302936
2025-10-02

MULTIVALENT PNEUMOCOCCAL VACCINES

 #5
20250222093
2025-07-10

METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF

 #6
20250108071
2025-04-03

INTRACELLULAR DELIVERY OF BIOMOLECULES TO INDUCE TOLERANCE

 #7
20250018037
2025-01-16

SAFETY CONTROL OF SWITCHABLE CHIMERIC ANTIGEN RECEPTOR T CELLS USING DOSE-ADJUSTABLE ADAPTORS

 #8
20240398924
2024-12-05

MULTIVALENT PNEUMOCOCCAL VACCINES

 #9
20240342263
2024-10-17

METHODS FOR MAKING POLYSACCHARIDE-PROTEIN CONJUGATES

 #10
20240181039
2024-06-06

INFLUENZA VACCINE FOR INTRANASAL ADMINISTRATION

 #11
20230390375
2023-12-07

MULTIVALENT PNEUMOCOCCAL VACCINES

 #12
20230190926
2023-06-22

Methods of producing bioconjugates of O-antigen polysaccharides, compositions thereof, and methods of use thereof

 #13
20230091255
2023-03-23

Multivalent pneumococcal vaccines

 #14
20230044044
2023-02-09

Monoclonal antibodies and cocktails for treatment of Ebola infections

 #15
20220133874
2022-05-05

Methods for making polysaccharide-protein conjugates

 #16
20220111041
2022-04-14

PHAGOCYTISABLE PARTICLE FOR USE IN THE TREATMENT OR PROPHYLAXIS OF CANCER

 #17
20210346487
2021-11-11

Multivalent pneumococcal vaccines

 #18
20210154291
2021-05-27

Immunostimulatory compositions, particles, and uses related thereto

 #19
20210100885
2021-04-08

CELLULAR IMMUNITY INDUCING VACCINE

 #20
20210100884
2021-04-08

CELLULAR IMMUNITY INDUCING VACCINE

 #21
20210000947
2021-01-07

Mucosal adjuvants and delivery systems

 #22
20200390881
2020-12-17

NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE

 #23
20200368338
2020-11-26

CONJUGATE OF WT1-DERIVED PEPTIDES AND COMPOSITION COMPRISING THE SAME

 #24
20200354438
2020-11-12

Monoclonal antibodies and cocktails for treatment of Ebola infections

 #25
20200354437
2020-11-12

Monoclonal antibodies and cocktails for treatment of Ebola infections

 #26
20200353073
2020-11-12

Methods of producing bioconjugates of o-antigen polysaccharides, compositions thereof, and methods of use thereof

 #27
20200345824
2020-11-05

Vaccine

 #28
20200299363
2020-09-24

Monoclonal antibodies and cocktails for treatment of Ebola infections

 #29
20200299362
2020-09-24

Monoclonal antibodies and cocktails for treatment of Ebola infections

 #30
20200299361
2020-09-24

Monoclonal antibodies and cocktails for treatment of Ebola infections

 #31
20200222522
2020-07-16

Multivalent pneumococcal vaccines

 #32
20200148734
2020-05-14

Method for improving resistance to breakage and eggshell strength

 #33
20200046821
2020-02-13

Methods for making polysaccharide-protein conjugates

 #34
20200000911
2020-01-02

IMMUNOGENIC COMPOSITION

 #35
20190298822
2019-10-03

Immunogenic composition

 #36
20190262447
2019-08-29

Vaccine

 #37
20190240309
2019-08-08

Pneumococcal polysaccharide-protein conjugate composition

 #38
20190231869
2019-08-01

Mucosal adjuvants and delivery systems

 #39
20190201540
2019-07-04

IMMUNOGENS, COMPOSITIONS, AND METHODS FOR TREATING DYSLIPIDEMIA

 #40
20190134191
2019-05-09

Alhydrogel-sodium chloride compound immunologic adjuvant, preparation method and use thereof

 #41
20190111082
2019-04-18

Intracellular delivery of biomolecules to induce tolerance

 #42
20180311370
2018-11-01

Method for prevention or treatment of one or more of diseases relevant to the protein in the protein-cell conjugate, malignant tumors, infectious diseases caused by pathogenic microorganisms and autoimmune diseases

 #43
20180256709
2018-09-13

IMMUNOMODULATORY AGENT-POLYMERIC COMPOUNDS

 #44
20180250389
2018-09-06

VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES

 #45
20180244758
2018-08-30

Monoclonal antibodies and cocktails for treatment of ebola infections

 #46
20180243395
2018-08-30

Injectable vaccines against multiple meningococcal serogroups

 #47
20180207262
2018-07-26

Pneumococcal capsular saccharide conjugate vaccine

 #48
20180117145
2018-05-03

Immunostimulatory compositions, particles, and uses related thereto

 #49
20180071386
2018-03-15

Silicon dioxide nanoparticles and the use thereof for vaccination

 #50
20180064806
2018-03-08

Immunogenic composition

 #51
20180044390
2018-02-15

FGF-23 epitope peptide for improving resistance to breakage and eggshell strength

 #52
20180043004
2018-02-15

Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants)

 #53
20170266301
2017-09-21

Particles comprising single stranded RNA and double stranded RNA for immunomodulation

 #54
20170143823
2017-05-25

Mucosal adjuvants and delivery systems

 #55
20170080080
2017-03-23

Combinatorial platform for the display of surface adjuvants and antigens

 #56
20170065714
2017-03-09

Immunogenic composition

 #57
20160375129
2016-12-29

Dimeric scaffold peptides comprising HIV-1 GP120 and GP41 epitopes

 #58
20160354457
2016-12-08

Injectable vaccines against multiple meningococcal serogroups

 #59
20160331819
2016-11-17

Tumor vascular marker-targeted vaccines

 #60
20160303228
2016-10-20

Silicon dioxide nanoparticles and the use thereof for vaccination

 #61
20160243219
2016-08-25

Vaccine comprising capsular polysaccharide conjugates

 #62
20160228561
2016-08-11

Protein-cell conjugate, preparation method and use thereof

 #63
20160193309
2016-07-07

Method to generate antibodies to ion channels

 #64
20160166665
2016-06-16

Cellular immunity inducing vaccine

 #65
20160030541
2016-02-04

Method of modifying the immune response

 #66
20150328300
2015-11-19

Immunomodulatory agent-polymeric compounds

 #67
20150265702
2015-09-24

Pneumoccal polysacchride conjugate vaccine

 #68
20150224189
2015-08-13

Silicon dioxide nanoparticles and the use thereof for vaccination

 #69
20150165017
2015-06-18

Shortened purification process for the production of capsular polysaccharides

 #70
20150125536
2015-05-07

Methods and compositions for sustained immunotherapy

 #71
20150125483
2015-05-07

Fusion proteins of ciliate granule lattice proteins, granular protein particles thereof, and uses therefor

 #72
20150024001
2015-01-22

MOLECULAR MIMIC MUCOSAL AIDS VACCINE

 #73
20140363463
2014-12-11

Shortened purification process for the production of capsular polysaccharides

 #74
20140348924
2014-11-27

Particles comprising single stranded RNA and double stranded RNA for immunomodulation

 #75
20140341909
2014-11-20

CONJUGATION OF BIOMOLECULES USING DIELS-ALDER CYCLOADDITION

 #76
20140242173
2014-08-28

TARGETED SYNTHETIC NANOCARRIERS WITH PH SENSITIVE RELEASE OF IMMUNOMODULATORY AGENTS

 #77
20140193453
2014-07-10

Immunomodulatory agent-polymeric compounds

 #78
20140186390
2014-07-03

Conjugation process of bacterial polysaccharides to carrier proteins

 #79
20140186389
2014-07-03

Conjugation process of bacterial polysaccharides to carrier proteins

 #80
20140044748
2014-02-13

Methods for preparing complex multivalent immunogenic conjugates

 #81
20140044746
2014-02-13

Dimeric scaffold proteins comprising HIV-1 GP120 and GP41 epitopes

 #82
20130095124
2013-04-18

Compositions for transfection of biomolecules into cells

 #83
20130011432
2013-01-10

Disrupted adenovirus-based vaccine against drugs of abuse

 #84
20130004532
2013-01-03

Process for manufacturing vaccines

 #85
20120321660
2012-12-20

Conjugation process of bacterial polysaccharides to carrier proteins

 #86
20120263728
2012-10-18

Method to generate antibodies to ion channels

 #87
20120207706
2012-08-16

A-β immunogenic peptide carrier conjugates and methods of producing same

 #88
20120195922
2012-08-02

Methods for preparing complex multivalent immunogenic conjugates

 #89
20120035529
2012-02-09

Tumor vascular marker-targeted vaccines

 #90
20110287042
2011-11-24

A-β immunogenic peptide carrier conjugates and methods of producing same

 #91
20110262472
2011-10-27

VACCINE COMPOSITIONS FOR THE TREATMENT OF DENGUE FEVER AND USES THEREOF

 #92
20110257377
2011-10-20

Covalently linked complexes of HIV TAT and ENV PROTEINS

 #93
20110250174
2011-10-13

Stable immunogenic product comprising antigenic heterocomplexes

 #94
20110229511
2011-09-22

METHOD OF MODIFYING THE IMMUNE RESPONSE

 #95
20110212122
2011-09-01

Nerve Growth Factor Conjugates and Uses Thereof

 #96
20110200632
2011-08-18

ADJUVANTING MATERIAL

 #97
20110171248
2011-07-14

SYNTHETIC VIRUS-LIKE PARTICLES CONJUGATED TO HUMAN PAPILLOMAVIRUS CAPSID PEPTIDES FOR USE AS VACCINES

 #98
20110142874
2011-06-16

Compositions, Methods, and Kits for Eliciting an Immune Response

 #99
20110123620
2011-05-26

Silicon dioxide nanoparticles and the use thereof for vaccination

 #100
20110097417
2011-04-28

MELAN-A-CARRIER CONJUGATES

 #101
20110038900
2011-02-17

Nanoparticles for use in pharmaceutical compositions

 #102
20110027217
2011-02-03

Immunomodulatory agent-polymeric compounds

 #103
20110020388
2011-01-27

TARGETED SYNTHETIC NANOCARRIERS WITH PH SENSITIVE RELEASE OF IMMUNOMODULATORY AGENTS

 #104
20100303850
2010-12-02

NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE

 #105
20100215686
2010-08-26

Process for manufacturing vaccines

 #106
20100189740
2010-07-29

MODIFIED POLYSACCHARIDES FOR CONJUGATE VACCINES

 #107
20100074922
2010-03-25

Pneumococcal polysaccharide conjugate vaccine

 #108
20100047331
2010-02-25

Method of inducing antibodies to human immunodeficiency virus involving the administration of MPER peptide-liposome conjugates

 #109
20090252759
2009-10-08

Immunogenic composition

 #110
20090136541
2009-05-28

Immunogenic composition

 #111
20090092632
2009-04-09

Methods for preparing complex multivalent immunogenic conjugates

 #112
20090041802
2009-02-12

Immunogenic composition

 #113
20090017072
2009-01-15

Vaccine

 #114
20090017060
2009-01-15

Cleavable vaccine compositions and uses thereof and methods of making and using the same

 #115
20090017059
2009-01-15

Vaccine Comprising Streptococcus Pneumoniae Capsular Polysaccharide Conjugates

 #116
20090010959
2009-01-08

Pneumococcal Polysaccharide Conjugate Vaccine

 #117
20080300385
2008-12-04

Covalently-linked complexes of HIV Tat and Env proteins

 #118
20080299082
2008-12-04

Novel recombinant T4 phage particle containing HIV, H. pylori or cancer antigens and uses thereof

 #119
20080299074
2008-12-04

A-BETA IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME

 #120
20080292704
2008-11-27

Methods and compositions involving polymeric immunoglobulin fusion proteins

 #121
20080286838
2008-11-20

Shortened purification process for the production of capsular polysaccharides

 #122
20080233143
2008-09-25

Adjuvanting Material

 #123
20080199490
2008-08-21

Immunogenic composition

 #124
20080193476
2008-08-14

Immunogenic composition

 #125
20080145373
2008-06-19

Aβ immunogenic peptide carrier conjugates and methods of producing same

 #126
20080008709
2008-01-10

Conjugation of biomolecules using Diels-Alder cycloaddition

 #127
20070253979
2007-11-01

Immunogenic Hiv Compositions and Related Methods

 #128
20070161088
2007-07-12

A-β immunogenic peptide carrier conjugates and methods of producing same

 #129
20070110762
2007-05-17

Process for preparing polysaccharide-protein conjugate vaccines

 #130
20070082014
2007-04-12

Injectable vaccines against multiple meningococcal serogroups

 #131
20060252033
2006-11-09

Carrier of a diamond fine particle for immobilizing virus

 #132
20060204475
2006-09-14

Melan-A- carrier conjugates

 #133
20060067944
2006-03-30

Stable immunogenic product comprising antigenic heterocomplexes

 #134
20060029615
2006-02-09

Novel recombinant T4 phage particle and uses thereof

 #135
20060013800
2006-01-19

Method for preparing a stable TNF-α vaccine

 #136
20050196411
2005-09-08

Immunogenic HIV compositions and related methods